<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Ranozex - Anti-anginal Drug</title>
<style>
        body {
            font-family: 'Arial', sans-serif;
            margin: 0;
            padding: 20px;
            background-color: #f4f4f4;
            color: #2c3e50;
        }
        .container {
            max-width: 900px;
            margin: auto;
            background: white;
            padding: 20px;
            border-radius: 12px;
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        h1 {
            text-align: center;
            color: #d35400;
            text-transform: uppercase;
        }
        h2 {
            color: #2980b9;
            border-bottom: 2px solid #2980b9;
            padding-bottom: 5px;
        }
        table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 15px;
            background: #ecf0f1;
            border-radius: 8px;
            overflow: hidden;
        }
        th, td {
            border: 1px solid #bdc3c7;
            padding: 12px;
            text-align: left;
        }
        th {
            background-color: #2980b9;
            color: white;
        }
        td {
            background-color: white;
        }
        .section {
            margin-top: 20px;
            padding: 15px;
            background: #eaf2f8;
            border-left: 5px solid #2980b9;
            border-radius: 8px;
        }
        .highlight {
            color: #e74c3c;
            font-weight: bold;
        }
        .footer {
            text-align: center;
            margin-top: 20px;
            font-size: 14px;
            color: #7f8c8d;
        }
</style>
  </head>
  <body>

    <div class="container">
	  <h1>Ranozex</h1>
	  <p><strong>Novel anti-anginal for better outcomes</strong></p>

	  

	  

	  <div class="section">
		<h2>Indication</h2>
		<p>For the treatment of <span class="highlight">chronic angina</span>.</p>
	  </div>

	  <div class="section">
		<h2>Dosage and Administration</h2>
		<p>
		  Initiate Ranolazine dosing at <span class="highlight">500 mg twice daily</span> and increase to 
		  <span class="highlight">1 gm twice daily</span> as needed, based on clinical symptoms. 
		  Take Ranolazine with or without meals. Tablets should be taken whole, not crushed, broken, or chewed.
		</p>
	  </div>

	  <div class="section">
		<h2>Positioning</h2>
		<p>For better outcomes, add in patients with chronic stable angina.</p>
	  </div>

	  <div class="section">
		<h2>Highlighting Points/ USPs</h2>
		<ul>
		  <li>Approved by <span class="highlight">US FDA</span> and <span class="highlight">EMEA (European Medicines Evaluation Agency)</span>.</li>
		  <li>It is a <span class="highlight">late sodium current inhibitor</span>, preventing sodium and calcium overload.</li>
		  <li>Prevents ischemia at the cellular level.</li>
		  <li>No change in HR or BP (No hemodynamic changes).</li>
		  <li>According to MARISA Trial, Ranozex improves exercise performance.</li>
		  <li>According to CARISA Trial, Ranozex therapy significantly reduces <span class="highlight">NTG consumption</span> per week.</li>
		  <li>According to ROLE Trial, Ranozex ensures long-term safety in high-risk <span class="highlight">CHD patients</span>.</li>
		</ul>
	  </div>

	  <div class="section">
		<h2>Brand’s Objective for Q3</h2>
		<ul>
		  <li><strong>Achieve 25% Prescription Share</strong></li>
		</ul>
	  </div>

	  <div class="section">
		<h2>Strategies for Q3</h2>
		<p>Increase prescribers' number by brand conversion.</p>
	  </div>


	  <div class="footer">
		<p>© 2025 Ranozex | All Rights Reserved</p>
	  </div>
    </div>

  </body>
</html>
